Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.
Ontoria, J.M., Biancofiore, I., Fezzardi, P., Ferrigno, F., Torrente, E., Colarusso, S., Bianchi, E., Andreini, M., Patsilinakos, A., Kempf, G., Augustin, M., Steinbacher, S., Summa, V., Pacifici, R., Munoz-Sanjuan, I., Park, L., Bresciani, A., Dominguez, C., Sherman, L.T., Harper, S.(2020) ACS Med Chem Lett 11: 740-746
- PubMed: 32435379 
- DOI: 10.1021/acsmedchemlett.9b00594
- Primary Citation of Related Structures:  
6SP1, 6SP4 - PubMed Abstract: 
The NRF2-ARE pathway is an intrinsic mechanism of defense against oxidative stress. Inhibition of the interaction between NRF2 and its main negative regulator KEAP1 is an attractive strategy toward neuroprotective agents. We report here the identification of nonacidic tetrahydroisoquinolines (THIQs) that inhibit the KEAP1/NRF2 protein-protein interaction ...